本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： ● 海利尔药业集团股份有限公司（以下简称"公司"）控股股东张爱英女士持有本公司股份为127,253,000 股，占公司总股本的37.44%，本次质押展期后，张爱英女士累计质押公司股份1,460,000股，占其持有 公司股份总数的1.15%，占公司总股本的0.43%。 登录新浪财经APP 搜索【信披】查看更多考评等级 二、股东累计质押股份情况 截至公告披露日，公司控股股东及其一致行动人累计质押股份情况如下： ■ 三、其他情况说明 张爱英女士资信状况良好，具备相应的资金偿还能力，其所质押的股份目前不存在平仓风险或被强制过 户风险，股份质押风险在可控范围内，不会导致公司的实际控制权发生变更、不会对公司日常经营和公 司治理稳定性产生影响。如后续出现风险，上述股东将采取包括但不限于补充质押、提前还款等措施加 以应对。公司将持续关注其股份质押情况及风险，并按照有关规定及时履行信息披露义务。敬请投资者 注意投资风险。 ● 截至本公告日，张爱英及其一致行动人葛尧伦、葛家成、青岛合 ...

证券日报网讯 11月11日晚间，海利尔发布公告称，公司于近日接到控股股东张爱英女士关于办理所持 股份质押展期的通知，本次质押展期股数为1，460，000股。 （文章来源：证券日报） ...

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 证券代码：603639 证券简称：海利尔 公告编号：2025-060 海利尔药业集团股份有限公司 关于控股股东股份质押展期的公告 重要内容提示： 海利尔药业集团股份有限公司（以下简称"公司"）控股股东张爱英女士 持有本公司股份为127,253,000股，占公司总股本的37.44%，本次质押展期后， 张爱英女士累计质押公司股份1,460,000股，占其持有公司股份总数的1.15%，占 公司总股本的0.43%。 截至本公告日，张爱英及其一致行动人葛尧伦、葛家成、青岛合意投资 中心（有限合伙）合计直接持有公司股份219，193，439股，占公司总股本的64.49%。 本次质押展期后，张爱英及其一致行动人葛尧伦、葛家成、青岛合意投资中心（有 限合伙）直接持有的公司股份中处于质押状态的股份累计数为1,460,000股，占 其合计所持公司股份总数的0.67%，占公司总股本的0.43%。 公司于近日接到控股股东张爱英女士关于办理所持股份质押展期的通知，具 体情况如下： 一、本次股份质押展期情况 ...

Core Insights - Hailir's stock price increased by 2.01% on November 7, reaching 13.72 CNY per share, with a total market capitalization of 4.663 billion CNY [1] - The company has seen a year-to-date stock price increase of 15.29%, but a decline of 6.22% over the past 20 days and 9.08% over the past 60 days [1] - Hailir's main business involves the production and sales of pesticide formulations and active ingredients, with 97.46% of revenue coming from pesticides [1] Financial Performance - For the period from January to September 2025, Hailir reported a revenue of 3.391 billion CNY, representing a year-on-year growth of 5.50%, and a net profit attributable to shareholders of 208 million CNY, up 6.15% year-on-year [2] - Cumulative cash dividends since the A-share listing amount to 1.255 billion CNY, with 680 million CNY distributed over the past three years [3] Shareholder Structure - As of September 30, 2025, Hailir had 13,000 shareholders, a decrease of 14.70% from the previous period, with an average of 26,229 circulating shares per shareholder, an increase of 17.23% [2] - The top ten circulating shareholders include new entrants such as招商量化精选股票发起式A and招商成长量化选股股票A, with significant holdings [3]

Investment Rating - The industry investment rating is maintained as "Positive" [5] Core Viewpoints - The recent US-China talks have led to a potential recovery in demand, which is expected to positively impact the chemical industry [7] - The energy storage sector is driving an optimistic outlook for lithium battery demand, particularly benefiting the phosphate rock segment due to its rigid supply characteristics [7] Summary by Sections Industry Overview - The chemical industry is facing challenges due to the US-China trade disputes, but recent negotiations have shown signs of easing tensions, which may stabilize demand [7] - The global energy storage battery shipments are projected to exceed 500 GWh in 2025, representing a year-on-year growth of approximately 60% [7] Investment Recommendations - The report recommends buying shares in companies that are well-positioned in the green polyester industry, such as Wankai New Materials (301216) [3] - Companies in the pesticide formulation sector, like Runfeng Co. (301035), Guoguang Co. (002749), and Hailier (603639), are also recommended for purchase due to their lower exposure to trade disputes [3] - The report highlights potential recovery in the petrochemical and chemical sectors, suggesting investments in Sinopec (600028), Hengli Petrochemical (600346), Rongsheng Petrochemical (002493), Wanhua Chemical (600309), and Huayi Group (600623) [3]

Core Points - The company has approved the first grant of restricted stock under the 2025 Restricted Stock Incentive Plan, with a total of 11.5 million shares to be granted to 618 recipients at a price of 7.28 yuan per share, effective on October 30, 2025 [2][6][23] Summary by Sections Grant Details - The first grant date for the restricted stock is set for October 30, 2025 [2] - A total of 11.5 million shares will be granted [2] - The grant price is established at 7.28 yuan per share [6] Decision Process - The decision-making process involved multiple meetings, including the board meeting on September 29, 2025, where the incentive plan was reviewed and approved [3][4] - The internal list of incentive recipients was publicly disclosed from October 9 to October 18, 2025, with no objections received [3] - The plan was approved by the shareholders at the first extraordinary general meeting on October 29, 2025 [4][5] Compliance and Conditions - The board confirmed that both the company and the recipients meet the necessary conditions for granting the restricted stock, as outlined in the relevant regulations [5][6] - The incentive plan includes performance assessment criteria that must be met for the release of the restricted stock [7][9] Financial Impact - The estimated total cost of the restricted stock incentive plan is projected to be 81.995 million yuan, with specific amortization details provided [19][20] - The actual financial impact will be determined based on the final audit report [20] Legal Opinions - Legal counsel has confirmed that all necessary approvals and authorizations for the stock grant have been obtained, and the conditions for granting the stock have been satisfied [21]

Core Viewpoint - Hailir, a significant player in the domestic pesticide industry, focuses on the research and production of pesticide formulations, active ingredients, and intermediates, showcasing substantial investment value due to its full industry chain advantages [1] Group 1: Business Performance - In Q3 2025, Hailir reported revenue of 3.391 billion yuan, ranking 12th among 32 peers, with the industry leader, Adama Agricultural Solutions, generating 21.678 billion yuan [2] - The main business revenue composition includes pesticide revenue of 3.808 billion yuan (97.46%), fertilizer revenue of 66.8459 million yuan (1.71%), and agricultural services revenue of 27.6076 million yuan (0.71%) [2] - The net profit for the same period was 208 million yuan, placing Hailir 11th in the industry, with the top performer, Yangnong Chemical, achieving a net profit of 1.056 billion yuan [2] Group 2: Financial Ratios - Hailir's debt-to-asset ratio in Q3 2025 was 50.39%, higher than the previous year's 47.12% and above the industry average of 46.06% [3] - The gross profit margin for Q3 2025 was 24.22%, slightly up from 24.05% year-on-year and above the industry average of 21.70% [3] Group 3: Shareholder Information - As of September 30, 2025, the number of A-share shareholders decreased by 14.70% to 13,000, while the average number of circulating A-shares held per shareholder increased by 17.23% to 26,200 [5] - Notable changes among the top ten circulating shareholders include new entries from two funds, with one holding 2.7215 million shares and another holding 1.5519 million shares [5] Group 4: Management Compensation - The chairman, Ge Jiacheng, received a salary of 1.8463 million yuan in 2024, an increase of 320,300 yuan from 2023 [4] Group 5: Market Outlook - Analysts predict a gradual improvement in Hailir's performance, with expected net profits for 2025-2027 of 396 million yuan, 503 million yuan, and 543 million yuan, respectively, despite downward adjustments in forecasts [6]

Group 1 - The pesticide sector has experienced significant adjustments, with Hailier hitting the daily limit down [1] - Other companies such as Changqing Co., Runfeng Co., Yangnong Chemical, Andermatt A, Sully Co., and Xianda Co. also saw declines [1]

证券代码：603639 证券简称：海利尔 公告编号：2025-058 海利尔药业集团股份有限公司 关于公司第五届董事会第十二次会议决议的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 2025 年 10 月 31 日 海利尔药业集团股份有限公司(以下简称"公司")第五届董事会第十二次会 议于 2025 年 10 月 30 日以通讯表决的方式召开。会议通知于 2025 年 10 月 27 日以电子邮件的方式发出，会议应到董事 9 名，实到董事 8 名，葛尧伦先生因个 人原因未出席会议。本次会议的召集和召开符合《中华人民共和国公司法》和《海 利尔药业集团股份有限公司章程》的有关规定，合法有效。 二、董事会会议审议情况 1、审议通过《关于向 2025 年限制性股票激励计划激励对象首次授予限制 性股票的议案》 根据《上市公司股权激励管理办法》《海利尔药业集团股份有限公司 2025 年 限制性股票激励计划（草案）》的有关规定，以及公司 2025 年第一次临时股东会 的授权，本次激励计划规定的授予条件已经成就 ...

证券代码：603639 证券简称：海利尔 公告编号：2025-059 海利尔药业集团股份有限公司 关于向 2025 年限制性股票激励计划激励对象 首次授予限制性股票的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 根据《上市公司股权激励管理办法》（以下简称"《管理办法》"）、《海利 尔药业集团股份有限公司 2025 年限制性股票激励计划（草案）》（以下简称"本 激励计划"、"激励计划"）的相关规定以及公司 2025 年第一次临时股东会授权， 海利尔药业集团股份有限公司（以下简称"公司"）董事会认为本次激励计划规定 的限制性股票的授予条件已经成就，公司于 2025 年 10 月 30 日召开的第五届董 事会第十二次会议审议通过《关于向 2025 年限制性股票激励计划激励对象首次 授予限制性股票的议案》，确定公司本次限制性股票的首次授予日为 2025 年 10 月 30 日。现将有关事项说明如下： 一、限制性股票的授予情况 （一）已履行的决策程序和信息披露情况 1、2025 年 9 月 29 日，公司召开第五 ...